drugset / Trial / NCT02482649

EAA/Therapy for Treating Children With ADHD

NCT02482649

RandomizedParallel-groupOpen-labelTreatment

Summary

The aim of this study is 1) to investigate clinical effects of equine-assisted activities and therapy (EAA/T) for treating attention-deficit/hyperactivity disorder (ADHD) and 2) to compare the clinical effect of EAA/T and drug therapy in children 6-13-years-of-age. This study is designed as a 12-week, prospective, open labeled trial, including 24 sessions of EAA/T. Forty six subjects will be enrolled and various clinical tests will be administered at baseline and after EAA/T or drug therapy.

Timeline

Start
2013-01
Primary completion
2015-08
Completion
2015-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Atomoxetine Other / unclassified
Comparator Methylphenidate Small molecule